The European Commission (EC) has approved OPUVIZ 40 mg/mL solution for injection in a vial. OPUVIZ is a biosimilar ...

Key findings include reduced lesion growth, retinal tissue preservation, and improved visual function, demonstrating significant potential for the treatment option. Ocugen Inc. announced positive ...

This year’s Barcelona meeting brought together award-winning research findings and leaders in the retina field. The European Society of Retina Specialists (Euretina) held its 24th annual congress in ...

Astellas Pharma Inc. announced the United States Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for avacincaptad pegol intravitreal solution (IZERVAY). In the November ...

AlloVir, Inc. has entered into a definitive merger agreement to combine with Kalaris Therapeutics in an all-stock transaction. Under the terms of the agreement, AlloVir will acquire 100% of the ...

A program from National Health Service (NHS) England will bring optical coherence tomography (OCT) scans “closer to home” for thousands of patients. As part of an effort to improve outcomes for ...

Like many, I was privileged to attend the annual American Academy of Ophthalmology (AAO) meeting in Chicago, Illinois, in October. As an educator, a highlight is always hearing updates from former ...

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio.

In a recent Modern Retina case-based discussion, Ferhina S. Ali, MD, MPH, discussed how to effectively manage geographic atrophy (GA). In a recent Modern Retina case-based discussion, Ferhina S. Ali, ...

This year’s Barcelona meeting brought together award-winning research findings and leaders in the retina field. Ian C. Han, MD, shares his thoughts on the value of anecdotal evidence in our winter ...